Obesity and Its Association with Chronic Diseases
DOI:
https://doi.org/10.36676/ssjmra.v1.i1.10Keywords:
Obesity, Chronic diseases, Cardiovascular diseases, Type 2 diabetes, Hypertension, CancerAbstract
The epidemic of obesity has evolved into a worldwide health concern, which poses significant challenges not only to individuals but also to healthcare systems in every corner of the world. the intricate connection that exists between obesity and chronic illnesses, shedding light on the several ways in which excessive levels of adiposity can have a detrimental impact on a person's health. An abnormal buildup of body fat, which is what obesity is, has been related to a broad variety of chronic illnesses such as diabetes, heart disease, and cancer. In addition to musculoskeletal problems and some forms of cancer, these diseases include cardiovascular diseases, type 2 diabetes, hypertension, and certain types of cancer. However, this list is not exhaustive. An abnormal buildup of fat in the body is one of the defining characteristics of obesity. This intricate connection is impacted by a number of different elements, such as heredity, environment, and lifestyle, and as a consequence, it has become an essential worry for the health of the general public. These associations are caused by a number of pathophysiological processes, including chronic low-grade inflammation, insulin resistance, dyslipidemia, and dysfunctional adipokines. The accumulation of these pathophysiological processes is a factor that contributes to the development and progression of chronic disorders. In addition, the comorbidities that are linked with obesity create a major financial burden on healthcare systems. This underscores the significance of creating effective approaches for the prevention and management of obesity through increased efficiency.
References
Bray, G. A., & Kim, K. K. (2017). Obesity and metabolic syndrome: Implications for treatment. Endocrinology and Metabolism Clinics, 46(4), 765-785.
Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860-867.
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444(7121), 840-846.
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., ... & Eckel, R. H. (2006). Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 113(6), 898-918.
Kopelman, P. G. (2000). Obesity as a medical problem. Nature, 404(6778), 635-643.
Saltiel, A. R., & Olefsky, J. M. (2017). Inflammatory mechanisms linking obesity and metabolic disease. Journal of Clinical Investigation, 127(1), 1-4.
Shoelson, S. E., Lee, J., & Goldfine, A. B. (2006). Inflammation and insulin resistance. Journal of Clinical Investigation, 116(7), 1793-1801.
Wajchenberg, B. L. (2000). Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews, 21(6), 697-738.
Zhang, Y., & Proenca, R. (2000). Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature, 423(6938), 34-41.
Flegal, K. M., Kruszon-Moran, D., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2016). Trends in obesity among adults in the United States, 2005 to 2014. JAMA, 315(21), 2284-2291.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Shodh Sagar Journal for Medical Research Advancement
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.